TITAN MEDICAL INC (TMD.CA) Stock Price & Overview

TSX:TMD • CA88830X8199

Current stock price

0.8 CAD
-0.04 (-4.76%)
Last:

The current stock price of TMD.CA is 0.8 CAD. Today TMD.CA is down by -4.76%. In the past month the price decreased by -29.2%. In the past year, price increased by 841.18%.

TMD.CA Key Statistics

52-Week Range0.045 - 1.52
Current TMD.CA stock price positioned within its 52-week range.
1-Month Range0.8 - 1.52
Current TMD.CA stock price positioned within its 1-month range.
Market Cap
35.4M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.06
Dividend Yield
N/A

TMD.CA Stock Performance

Today
-4.76%
1 Week
-11.11%
1 Month
-29.20%
3 Months
+1,500.00%
Longer-term
6 Months +1,354.55%
1 Year +841.18%
2 Years +23.08%
3 Years -11.11%
5 Years -6.98%
10 Years -98.14%

TMD.CA Stock Chart

TITAN MEDICAL INC / TMD Daily stock chart

TMD.CA Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to TMD.CA. When comparing the yearly performance of all stocks, TMD.CA is one of the better performing stocks in the market, outperforming 99.94% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

TMD.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to TMD.CA. TMD.CA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TMD.CA Earnings

Next Earnings DateN/A
Last Earnings DateNov 7, 2024
PeriodQ2 / 2024
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

TMD.CA Forecast & Estimates


Analysts
Analysts80
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

TMD.CA Groups

Sector & Classification

Index Membership

TMD.CA Financial Highlights

Over the last trailing twelve months TMD.CA reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS increased by 65.9% compared to the year before.


Income Statements
Revenue(TTM)950.00K
Net Income(TTM)-5.05M
Industry RankSector Rank
PM (TTM) N/A
ROA -111.81%
ROE -184.94%
Debt/Equity 0.22
Chartmill High Growth Momentum
EPS Q2Q%-109.99%
Sales Q2Q%-100%
EPS 1Y (TTM)65.9%
Revenue 1Y (TTM)-94.31%

TMD.CA Ownership

Ownership
Inst Owners0.46%
Shares44.25M
Float12.48M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About TMD.CA

Company Profile

TMD logo image Conavi Medical Corp is a CA-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Toronto, Ontario and currently employs 4 full-time employees. The company went IPO on 2008-04-28. Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The firm is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.

Company Info

IPO: 2008-04-28

TITAN MEDICAL INC

76 Berkeley Street

TORONTO ONTARIO M5H 3B7 CA

CEO: David J. McNally

Employees: 4

TMD Company Website

Phone: 14165487522

TITAN MEDICAL INC / TMD.CA FAQ

Can you describe the business of TITAN MEDICAL INC?

Conavi Medical Corp is a CA-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Toronto, Ontario and currently employs 4 full-time employees. The company went IPO on 2008-04-28. Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The firm is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.


What is the stock price of TITAN MEDICAL INC today?

The current stock price of TMD.CA is 0.8 CAD. The price decreased by -4.76% in the last trading session.


Does TITAN MEDICAL INC pay dividends?

TMD.CA does not pay a dividend.


What is the ChartMill technical and fundamental rating of TMD stock?

TMD.CA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


How is the valuation of TITAN MEDICAL INC (TMD.CA) based on its PE ratio?

TITAN MEDICAL INC (TMD.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.06).


Can you provide the market cap for TITAN MEDICAL INC?

TITAN MEDICAL INC (TMD.CA) has a market capitalization of 35.40M CAD. This makes TMD.CA a Nano Cap stock.